20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Menin Interacts with IQGAP1 to Enhance Intercellular Adhesion of β Cells

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Multiple endocrine neoplasia type 1 (MEN1) is a dominantly inherited tumor syndrome that results from the mutation of the MEN1 gene that encodes protein menin. Stable overexpression of MEN1 has been shown to partially suppress the RAS-mediated morphological changes of NH3 fibroblast cells. Little is known about the molecular mechanisms by which menin decreases the oncogenic effects on cell morphology and other phenotypes. Here we showed that ectopic expression of menin in pretumor beta cells increases islet cell adhesion and reduces cell migration. Our further studies revealed that menin interacts with the scaffold protein, IQGAP1, reduces GTP-Rac1 interaction with IQGAP1 but increases E-cadherin/ß-catenin interaction with IQGAP1. Consistent with an essential role for menin in regulating ß cell adhesion in vivo, accumulations of β-catenin and E-cadherin are reduced at cell junctions in the islets from Men1-excised mice. Together, these results define a novel menin-IQGAP1 pathway that controls cell migration and cell-cell adhesion in endocrine cells.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Positional cloning of the gene for multiple endocrine neoplasia-type 1.

          Multiple endocrine neoplasia-type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by tumors in parathyroids, enteropancreatic endocrine tissues, and the anterior pituitary. DNA sequencing from a previously identified minimal interval on chromosome 11q13 identified several candidate genes, one of which contained 12 different frameshift, nonsense, missense, and in-frame deletion mutations in 14 probands from 15 families. The MEN1 gene contains 10 exons and encodes a ubiquitously expressed 2.8-kilobase transcript. The predicted 610-amino acid protein product, termed menin, exhibits no apparent similarities to any previously known proteins. The identification of MEN1 will enable improved understanding of the mechanism of endocrine tumorigenesis and should facilitate early diagnosis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

            The Mixed-Lineage Leukemia (MLL) protein is a histone methyltransferase that is mutated in clinically and biologically distinctive subsets of acute leukemia. MLL normally associates with a cohort of highly conserved cofactors to form a macromolecular complex that includes menin, a product of the MEN1 tumor suppressor gene, which is mutated in heritable and sporadic endocrine tumors. We demonstrate here that oncogenic MLL fusion proteins retain an ability to stably associate with menin through a high-affinity, amino-terminal, conserved binding motif and that this interaction is required for the initiation of MLL-mediated leukemogenesis. Furthermore, menin is essential for maintenance of MLL-associated but not other oncogene induced myeloid transformation. Acute genetic ablation of menin reverses aberrant Hox gene expression mediated by MLL-menin promoter-associated complexes, and specifically abrogates the differentiation arrest and oncogenic properties of MLL-transformed leukemic blasts. These results demonstrate that a human oncoprotein is critically dependent on direct physical interaction with a tumor suppressor protein for its oncogenic activity, validate a potential target for molecular therapy, and suggest central roles for menin in altered epigenetic functions underlying the pathogenesis of hematopoietic cancers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.

              The cellular function of the menin tumor suppressor protein, product of the MEN1 gene mutated in familial multiple endocrine neoplasia type 1, has not been defined. We now show that menin is associated with a histone methyltransferase complex containing two trithorax family proteins, MLL2 and Ash2L, and other homologs of the yeast Set1 assembly. This menin-associated complex methylates histone H3 on lysine 4. A subset of tumor-derived menin mutants lacks the associated histone methyltransferase activity. In addition, menin is associated with RNA polymerase II whose large subunit carboxyl-terminal domain is phosphorylated on Ser 5. Men1 knockout embryos and cells show decreased expression of the homeobox genes Hoxc6 and Hoxc8. Chromatin immunoprecipitation experiments reveal that menin is bound to the Hoxc8 locus. These results suggest that menin activates the transcription of differentiation-regulating genes by covalent histone modification, and that this activity is related to tumor suppression by MEN1.
                Bookmark

                Author and article information

                Journal
                8711562
                6325
                Oncogene
                Oncogene
                0950-9232
                1476-5594
                18 November 2008
                15 December 2008
                19 February 2009
                19 August 2009
                : 28
                : 7
                : 973-982
                Affiliations
                [1 ]Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA19014
                [2 ]Department of Biology, University of Virginia; Charlottesville, VA 22903
                [3 ]Department of Cell Biology, University of Virginia; Charlottesville, VA 22903
                [4 ]Proteomic Facility: University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA19014
                [5 ]Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
                Author notes
                [* ]Corresponding author: phone, 215 746-5565; email: huax@ 123456mail.med.upenn.edu
                Article
                nihpa77188
                10.1038/onc.2008.435
                2645484
                19079338
                543ae45d-2765-458f-a77e-b6725ef44bea
                History
                Funding
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Funded by: National Cancer Institute : NCI
                Award ID: R01 NS051746-04 ||NS
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Funded by: National Cancer Institute : NCI
                Award ID: R01 NS051746-03 ||NS
                Funded by: National Institute of Neurological Disorders and Stroke : NINDS
                Funded by: National Cancer Institute : NCI
                Award ID: R01 CA113962-04 ||CA
                Categories
                Article

                Oncology & Radiotherapy
                migration,iqgap1,menin,intercellular adhesion
                Oncology & Radiotherapy
                migration, iqgap1, menin, intercellular adhesion

                Comments

                Comment on this article